abstract |
The present invention provides compounds of formula (I) which are inhibitors of the PDE1 enzyme and their use as medicaments, in particular for the treatment of neurodegenerative and psychiatric disorders. The present invention also provides pharmaceutical compositions comprising the compounds of the present invention and methods of treating disorders using the compounds of the present invention. |